GöteborgBIO - bilder

Karin Ekström

GöteborgBIO — Wed, 30 May 2012 19:43:09 +0200

Karin Ekström, BIOMATCELL

Erik Forsberg, Managing Director, Uppsala BIO

GöteborgBIO — Tue, 20 Mar 2012 09:39:00 +0100

Erik Forsberg, Managing Director, Uppsala BIO

BIO-X

GöteborgBIO — Tue, 20 Mar 2012 09:30:37 +0100

Uppsala BIO och GöteborgBIO har ingått ett samarbetsavtal som ska intensifiera ansträngningarna med att överbrygga gapet mellan grundforskning, klinisk tillämpning och industriell produktutveckling. Samarbetet gäller BIO-X, den modell för öppen innovation som Uppsala BIO utvecklat framgångsrikt under flera år, som nu också blir tillgänglig för forskare i hela Västra Götalandsregionen.

Immunicum enrolls the first patient in its COMBIG clinical phase I/II-trial in renal cell carcinoma.

GöteborgBIO — Mon, 12 Mar 2012 09:26:25 +0100

In total, 12 patients with metastasis cancer of the kidney are being treated in order to investigate possible side effects and the antitumour effect of the vaccine. "“We are looking forward to the study and hope that a future kidney cancer vaccine will help a large number of people that cannot be effectively helped today," says Jamal El-Mosleh, Immunicum´s CEO.

the OPRA implant system — Osseointegrated Prosthetics for the Rehabilitation of Amputees

GöteborgBIO — Mon, 13 Feb 2012 14:40:52 +0100

Bone anchored prostheses are attached directly to the bone and do not have any contact with the skin. Many of the prosthesis related problems are eliminated and the functional ability of the patient is improved. The technique is called OPRA implant system — Osseointegrated Prosthetics for the Rehabilitation of Amputees, from the company Integrum, Gothenburg, Sweden.

Charlotta Lindwall

GöteborgBIO — Mon, 23 Jan 2012 16:04:35 +0100

Charlotta Lindwall, University of Gothenburg.

Iris Öhrn

GöteborgBIO — Fri, 13 Jan 2012 00:03:10 +0100

Iris Öhrn, Investment Manager Life Science at Business Region Göteborg

Anna-Carin Olin

GöteborgBIO — Fri, 06 Jan 2012 09:12:44 +0100

Anna-Carin Olin, Senior Lecturer, Sahlgrenska University Hospital

Professor Suchitra Holgersson

GöteborgBIO — Tue, 03 Jan 2012 12:13:17 +0100

Professor Suchitra Holgersson

Professor Michael Olausson

GöteborgBIO — Tue, 03 Jan 2012 12:11:00 +0100

Professor Michael Olausson

Medfield Diagnostics AB, StrokefinderR10 on patient

GöteborgBIO — Fri, 18 Nov 2011 11:49:51 +0100

Medfield's first product, Strokefinder R10, is an instrument for researchers within stroke and neurological research. It is versatile and can be used both for snapshot measurements to differentiate between ischemic (blood clot) and hemorrhagic stroke (bleeding in brain tissue) as well as to monitor changes over time.

S-Cut emergency rescue tool

GöteborgBIO — Tue, 13 Sep 2011 15:01:03 +0200

S-CUT is designed for use on patients in rescue situations as well as emergency situations in hospitals. It is a fast way to remove the patient’s clothes in order to expose injuries without needing to change the patient’s position which could inflict further injury or unnecessary pain.

Margareta Berg

GöteborgBIO — Fri, 12 Aug 2011 12:47:04 +0200

Margareta Berg MD PhD Consultant Orthopaedic Surgeon Phone +46 (0)708 441 999 congress@surgicon.org www.surgicon.org

Surgical Training

GöteborgBIO — Fri, 12 Aug 2011 12:40:00 +0200

Surgical Training

Maud Olofsson tries the Strokefinder R10

GöteborgBIO — Tue, 17 May 2011 16:41:00 +0200

Medfield Diagnostics is developing the diagnostic instrument Strokefinder R10, a helmet that uses microwaves to quickly determine whether a patient has been affected by a clot or haemorrhage in the brain. During a visit in Göteborg, Maud Olofsson, the Swedish Minister for Enterprise and Energy, did not hesitate to try it on.

Logotype for TERM - Tissue Engineering and Regenerative Medicine

GöteborgBIO — Thu, 31 Mar 2011 11:32:59 +0200

TERM - Tissue Engineering and Regenerative Medicine.

Nanofabrication Laboratory MC2, Chalmers, Göteborg

GöteborgBIO — Sun, 06 Feb 2011 14:46:00 +0100

Chalmers MC2 Nanofabrication Laboratory- bild 1

Nanofabrication Laboratory, MC2, Chalmers, Göteborg

GöteborgBIO — Sun, 06 Feb 2011 14:45:00 +0100

Nanofabrication Laboratory, MC2, Chalmers, Göteborg- bild 2 Jan-Olof Yxell

Fredrik Höök

GöteborgBIO — Tue, 11 Jan 2011 14:41:25 +0100

Professor Fredrik Höök, Biological Physics, Chalmers University of Technology, Gothenburg. Keynote speaker at NanoTechnology in Biotech Applications Seminar on February 10, 2011. Seminar organised by GöteborgBIO and Nano Connect Scandinavia, Göteborg.

Simplexia - Göteborgsbaserat projekt som utvecklar vaccin mot genital herpes

GöteborgBIO — Mon, 20 Dec 2010 10:38:14 +0100

Simplexia har sitt ursprung i Sahlgrenska akademin och GIBBS i Göteborg där en forskningsgrupp har identifierat ett protein som kan användas som ett vaccin mot genital herpes (herpes simplex virus typ 2, HSV-2).